Enhanced Detection of Diffusion Reductions in Creutzfeldt-Jakob Disease at a Higher B Factor

References

1. 1.↵
   1. DeArmond SJ,
   2. Prusiner SB

   . Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin Lab Med 2003; 23: 1–41

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Johnson RT,
   2. Gibbs CJ Jr..

   . Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998; 339: 1994–2004

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Young GS,
   2. Geschwind MD,
   3. Fischbein NJ,
   4. et al

   . Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005; 26: 1551–62

   Abstract/FREE Full Text
4. 4.↵
   1. Shiga Y,
   2. Miyazawa K,
   3. Sato S,
   4. et al

   . Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63: 443–49

   Abstract/FREE Full Text
5. 5.↵
   1. Tofts P

   ed. Quantitative MRI of the Brain: Measuring Changes Caused by Disease. West Sussex, UK: John Wiley; 2004
6. 6.↵
   1. Kim HJ,
   2. Choi CG,
   3. Lee DH,
   4. et al

   . High-b-value diffusion-weighted MR imaging of hyperacute ischemic stroke at 1.5T. AJNR Am J Neuroradiol 2005; 26: 208–15

   Abstract/FREE Full Text
7. 7.↵
   1. Yoshiura T,
   2. Mihara F,
   3. Tanaka A,
   4. et al

   . High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer’s disease. Neuroimage 2003; 20: 413–19

   CrossRefPubMed
8. 8.↵
   1. Assaf Y,
   2. Mayzel-Oreg O,
   3. Gigi A,
   4. et al

   . High b value q-space-analyzed diffusion MRI in vascular dementia: a preliminary study. J Neurol Sci 2002; 203–204: 235–39
9. 9.↵
   1. Burdette JH,
   2. Durden DD,
   3. Elster AD,
   4. et al

   . High b-value diffusion-weighted MRI of normal brain. J Comput Assist Tomogr 2001; 25: 515–19

   CrossRefPubMed
10. 10.↵
    Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: Emerging and Other Communicable Diseases, Surveillance and Control. Geneva, Switzerland: World Health Organization; 1998
11. 11.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Chapman J,
    2. Cohen O,
    3. Nitzan Z,
    4. et al

    . The CJD rating scale: a new tool for evaluation of neurologic symptomatology in early CJD patients. Neurology 2007; 68: A141

    CrossRef
13. 13.↵
    1. Stejskal EO,
    2. Tanner JE

    . Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys 1965; 42: 288–92

    CrossRefWeb of Science
14. 14.↵
    1. Mukherjee P,
    2. Chung SW,
    3. Berman JI,
    4. et al

    . Diffusion tensor MR imaging and fiber tractography: technical considerations. AJNR Am J Neuroradiol 2008; 29: 843–52

    Abstract/FREE Full Text
15. 15.↵
    1. Skare S,
    2. Andersson JL

    . On the effects of gating in diffusion imaging of the brain using single shot EPI. Magn Reson Imaging 2001; 19: 1125–28

    CrossRefPubMed
16. 16.↵
    1. Dietrich O,
    2. Heiland S,
    3. Benner T,
    4. et al

    . Reducing motion artifacts in diffusion-weighted MRI of the brain: efficacy of navigator echo correction and pulse triggering. Neuroradiology 2000; 42: 85–91

    CrossRefPubMed
17. 17.↵
    1. Mazziotta J,
    2. Toga A,
    3. Evans A,
    4. et al

    . A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM).Philos Trans R Soc Lond B Biol Sci 2001; 356: 1293–322

    Abstract/FREE Full Text
18. 18.↵
    1. Ashburner J,
    2. Friston KJ

    . Unified segmentation. Neuroimage 2005; 26: 839–51

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Brian P,
    2. Smith S,
    3. Kennedy D,
    4. et al

    . FIRST: FMRIB’s integrated registration and segmentation tool. In: Proceedings of Human Brain Mapping Conference, June 10–14, 2007, Chicago, Illinois.
20. 20.↵
    1. Fulbright RK,
    2. Hoffmann C,
    3. Lee H,
    4. et al

    . MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008; 29: 1638–43

    Abstract/FREE Full Text
21. 21.↵
    1. Lee H,
    2. Rosenmann H,
    3. Chapman J,
    4. et al

    . Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain 2009; 132: 2680–87 Epub 2009 March 24

    Abstract/FREE Full Text
22. 22.↵
    1. Kallenberg K,
    2. Schulz-Schaeffer WJ,
    3. Jastrow U,
    4. et al

    . Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol 2006; 27: 1459–62

    Abstract/FREE Full Text
23. 23.↵
    1. Lin YR,
    2. Young GS,
    3. Chen NK,
    4. et al

    . Creutzfeldt-Jakob disease involvement of rolandic cortex: a quantitative apparent diffusion coefficient evaluation. AJNR Am J Neuroradiol 2006; 27: 1755–59

    Abstract/FREE Full Text
24. 24.↵
    1. Tschampa HJ,
    2. Murtz P,
    3. Flacke S,
    4. et al

    . Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 2003; 24: 908–15

    Abstract/FREE Full Text
25. 25.↵
    1. Fulbright RK,
    2. Kingsley PB,
    3. Guo X,
    4. et al

    . The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation. Magn Reson Imaging 2006; 24: 1121–29

    CrossRefPubMedWeb of Science
26. 26.
    1. Nitrini R,
    2. Areza-Fegyveres R,
    3. Martins VR,
    4. et al

    . Asymmetric cortical high signal on diffusion weighted-MRI in a case of Creutzfeldt-Jakob disease. [in Portuguese]. Arq Neuropsiquiatr 2005; 63: 519–22. Epub 2005 Jul 25

    PubMed
27. 27.
    1. Bavis J,
    2. Reynolds P,
    3. Tegeler C,
    4. et al

    . Asymmetric neuroimaging in Creutzfeldt-Jakob disease: a ruse. J Neuroimaging 2003; 13: 376–79

    PubMed
28. 28.
    1. Wakisaka Y,
    2. Santa N,
    3. Doh-ura K,
    4. et al

    . Increased asymmetric pulvinar magnetic resonance imaging signals in Creutzfeldt-Jakob disease with florid plaques following a cadaveric dura mater graft. Neuropathology 2006; 26: 82–88

    CrossRefPubMed
29. 29.
    1. Yoon SS,
    2. Chan S,
    3. Chin S,
    4. et al

    . MRI of Creutzfeldt-Jakob disease: asymmetric high signal intensity of the basal ganglia. Neurology 1995; 45: 1932–33

    Abstract/FREE Full Text
30. 30.
    1. Ukisu R,
    2. Kushihashi T,
    3. Tanaka E,
    4. et al

    . Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics 2006; 26 (suppl 1): S191–204

    CrossRefPubMed
31. 31.↵
    1. Ukisu R,
    2. Kushihashi T,
    3. Kitanosono T,
    4. et al

    . Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2005; 184: 560–66

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Asao C,
    2. Hirai T,
    3. Yoshimatsu S,
    4. et al

    . Human cerebral cortices: signal variation on diffusion-weighted MR imaging. Neuroradiology 2008; 50: 205–11

    CrossRefPubMed
33. 33.↵
    1. Tschampa HJ,
    2. Kallenberg K,
    3. Kretzschmar HA,
    4. et al

    . Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2007; 28: 1114–18

    Abstract/FREE Full Text
34. 34.↵
    1. Krasnianski A,
    2. Kallenberg K,
    3. Collie DA,
    4. et al

    . MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study. Eur J Neurol 2008; 15: 762–71

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Meissner B,
    2. Kallenberg K,
    3. Sanchez-Juan P,
    4. et al

    . Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2008; 29: 1519–24

    Abstract/FREE Full Text
36. 36.↵
    1. Meissner B,
    2. Kortner K,
    3. Bartl M,
    4. et al

    . Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 2004; 63: 450–56

    Abstract/FREE Full Text
37. 37.↵
    1. Russmann H,
    2. Vingerhoets F,
    3. Miklossy J,
    4. et al

    . Sporadic Creutzfeldt-Jakob disease: a comparison of pathological findings and diffusion weighted imaging. J Neurol 2005; 252: 338–42

    CrossRefPubMed
38. 38.↵
    1. Haik S,
    2. Dormont D,
    3. Faucheux BA,
    4. et al

    . Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol 2002; 51: 797–99

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Mittal S,
    2. Farmer P,
    3. Kalina P,
    4. et al

    . Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002; 59: 128–34

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Mueggler T,
    2. Meyer-Luehmann M,
    3. Rausch M,
    4. et al

    . Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur J Neurosci 2004; 20: 811–17

    CrossRefPubMed
41. 41.↵
    1. Brugieres P,
    2. Thomas P,
    3. Maraval A,
    4. et al

    . Water diffusion compartmentation at high b values in ischemic human brain. AJNR Am J Neuroradiol 2004; 25: 692–98

    Abstract/FREE Full Text
42. 42.↵
    1. Clark CA,
    2. Le Bihan D

    . Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med 2000; 44: 852–59

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Niendorf T,
    2. Dijkhuizen RM,
    3. Norris DG,
    4. et al

    . Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med 1996; 36: 847–57

    PubMedWeb of Science
44. 44.↵
    1. Bar-Shir A,
    2. Cohen Y

    . High b-value q-space diffusion MRS of nerves: structural information and comparison with histological evidence. NMR Biomed 2008; 21: 165–74

    CrossRefPubMed
45. 45.↵
    1. Mulkern RV,
    2. Gudbjartsson H,
    3. Westin CF,
    4. et al

    . Multi-component apparent diffusion coefficients in human brain. NMR Biomed 1999; 12: 51–62

    CrossRefPubMedWeb of Science
46. 46.↵
    1. DeLano MC,
    2. Cooper TG,
    3. Siebert JE,
    4. et al

    . High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. AJNR Am J Neuroradiol 2000; 21: 1830–36

    Abstract/FREE Full Text